We continue to make meaningful investments in the Sterigenics capacity and expect to begin seeing revenue contributions from the expansions that Michael referenced beginning in the first half of 2022. We also continue to make progress on the facility enhancements at our North American EO facilities. For Nordion, Q2 revenue grew by 42% compared to Q3 of 2020 to $29 million. Nordion segment income grew 59% to $16 million compared to the same period last year.